1. Home
  2. EW vs A Comparison

EW vs A Comparison

Compare EW & A Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EW
  • A
  • Stock Information
  • Founded
  • EW 1958
  • A 1999
  • Country
  • EW United States
  • A United States
  • Employees
  • EW N/A
  • A N/A
  • Industry
  • EW Industrial Specialties
  • A Biotechnology: Laboratory Analytical Instruments
  • Sector
  • EW Health Care
  • A Industrials
  • Exchange
  • EW Nasdaq
  • A Nasdaq
  • Market Cap
  • EW 39.3B
  • A 37.5B
  • IPO Year
  • EW 2000
  • A 1999
  • Fundamental
  • Price
  • EW $70.48
  • A $133.83
  • Analyst Decision
  • EW Buy
  • A Buy
  • Analyst Count
  • EW 21
  • A 17
  • Target Price
  • EW $76.60
  • A $143.07
  • AVG Volume (30 Days)
  • EW 5.1M
  • A 2.0M
  • Earning Date
  • EW 10-24-2024
  • A 11-25-2024
  • Dividend Yield
  • EW N/A
  • A 0.71%
  • EPS Growth
  • EW 193.69
  • A 25.91
  • EPS
  • EW 6.89
  • A 4.81
  • Revenue
  • EW $6,314,900,000.00
  • A $6,497,000,000.00
  • Revenue This Year
  • EW $0.34
  • A N/A
  • Revenue Next Year
  • EW $1.64
  • A $5.30
  • P/E Ratio
  • EW $10.23
  • A $27.80
  • Revenue Growth
  • EW 24.02
  • A N/A
  • 52 Week Low
  • EW $58.93
  • A $123.48
  • 52 Week High
  • EW $96.12
  • A $155.35
  • Technical
  • Relative Strength Index (RSI)
  • EW 61.21
  • A 49.97
  • Support Level
  • EW $65.31
  • A $124.89
  • Resistance Level
  • EW $71.08
  • A $143.07
  • Average True Range (ATR)
  • EW 1.80
  • A 3.36
  • MACD
  • EW 0.45
  • A 0.02
  • Stochastic Oscillator
  • EW 90.23
  • A 49.17

About EW Edwards Lifesciences Corporation

Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. It has established itself as a leader across key products, including surgical tissue heart valves, transcatheter valve technologies, surgical clips, and catheters. The firm derives about 55% of its total sales from outside the US.

About A Agilent Technologies Inc.

Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life sciences and diagnostics firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and applied tools, cross lab (consisting of consumables and services related to life science and applied tools), and diagnostics and genomics. Over half of its sales are generated from the biopharmaceutical, chemical, and advanced materials end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the U.S. and China representing the largest country concentrations.

Share on Social Networks: